Oncology

Immune-checkpoint inhibitors (ICI) are an indispensable part of first-line treatment concepts for most patients with metastatic non-small…

Cancer immunotherapy has transformed outcomes for patients with advanced non-small cell lung cancer (NSCLC), enabling long-term survival…

This work addresses an important evidence gap in the use of immune checkpoint inhibitors among patients with pre-existing hepatitis C virus…

Brain metastases (BM) represent one of the most clinically significant complications of human epidermal growth factor receptor 2…

Previous studies have demonstrated that patients with RAS-mutant metastatic colorectal cancer (mCRC) occasionally develop RAS wild-type…

Molecular profiling has advanced colorectal cancer (CRC) research but remains limited in the clinic due to cost and tissue constraints…

Certification in Hematology and Oncology requires mastery of increasingly complex clinical knowledge. Despite this, approximately 8% of…

Thorough understanding of cancer therapeutics is a critical component of hematology–oncology (HO) training, with pharmacology…